Efficacy and safety of sugammadex (Org 25969) in reversing moderate neuromuscular block induced by rocuronium or vecuronium in Japanese patients

Japanese Journal of Anesthesiology

Volumn 63, Issue 10, 2014, Pages 1075-1082

  Takeda, Junzo ^a,b   Iwasaki, Hiroshi ^c   Yamakage, Michiaki ^d   Ozaki, Makoto ^e   Kawamata, Miwako ^f   Hatano, Yoshio ^g   Yorozuya, Toshihiro ^h,i   Miyakawa, Hiroshi ^j   Kanmura, Yuichi ^k  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NATIONAL HOSPITAL ORGANIZATION TOKYO MEDICAL CENTER   (Japan)

^c ASAHIKAWA MEDICAL COLLEGE   (Japan)

^d SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^f TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^g WAKAYAMA MEDICAL UNIVERSITY   (Japan)

^h EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

ⁱ OITA UNIVERSITY   (Japan)

^j Noguchi Thyroid Clinic and Hospital Foundation   (Japan)

^k KAGOSHIMA UNIVERSITY   (Japan)

more..

Author keywords

Non depolarizing muscle relaxant; Rocuronium; Selective relaxant binding agent; Sugammadex; Vecuronium

Indexed keywords

PLACEBO; ROCURONIUM; SEVOFLURANE; SUGAMMADEX; VECURONIUM; ANDROSTANE DERIVATIVE; GAMMA CYCLODEXTRIN DERIVATIVE; NEUROMUSCULAR BLOCKING AGENT;

ARTICLE; DRUG BLOOD LEVEL; HUMAN; JAPANESE (PEOPLE); MAJOR CLINICAL STUDY; NEUROMUSCULAR BLOCKING; ADULT; ANESTHETIC RECOVERY; ANTAGONISTS AND INHIBITORS; ASIAN CONTINENTAL ANCESTRY GROUP; CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; GENERAL ANESTHESIA; MALE; MIDDLE AGED; PHASE 2 CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL; YOUNG ADULT;

ADULT; ANDROSTANOLS; ANESTHESIA RECOVERY PERIOD; ANESTHESIA, GENERAL; ASIAN CONTINENTAL ANCESTRY GROUP; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GAMMA-CYCLODEXTRINS; HUMANS; MALE; MIDDLE AGED; NEUROMUSCULAR BLOCKADE; NEUROMUSCULAR NONDEPOLARIZING AGENTS; VECURONIUM BROMIDE; YOUNG ADULT;

EID: 84908506961     PISSN: 00214892     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Jones RK, Caldwell JE, Brull SJ, Soto RG. Reversal of profound rocuronium-induced blockade with sugammadex : a randomized comparison with neostigmine. Anesthesiology 2008; 109 : 816-24.
2. Adam JM, Bennett DJ, Bom A, Clark JK, Feilden H, Hutchinson EJ, et al., Cyclodextrin-derived host molecules as reversal agents for the neuromuscular blocker rocuronium bromide : synthesis and structure-activity relationships. J Med Chem 2002; 45 : 1806-16.
3. Bom A, Bradley M, Cameron K, Clark JK, van Egmond J, Feilden H, et aL A novel concept of reversing neuromuscular block : chemical encapsulation of rocuronium bromide by a cyclodextrin-based synthetic host Angew Chem Int Ed 2002; 41 : 266-70.
4. Blobner M, Eriksson LI Scholz J, Motsch J, Rocca GD, Prins ME. Reversal of rocuronium-induced neuromuscular blockade with sugammadex compared with neostigmine during sevoflurane anaesthesia : results of a randomized controlled trial Eur J Anaesthesiol 2010; 27 : 874-81.
5. Pühringer FK, Gordon M, Demeyer I, Sparr HJ, Ingimarsson J, Klarin B, et al. Sugammadex rapidly reverses moderate rocuronium-or vecuronium-induced neuromuscular block during sevoflurane anaesthesia : a dose-response relationship. Br J Anaesth 2010; 105 : 610-9.
6. Lee C, Jahr JS, Candiotti KA, Warmer B, Zornow MH, Naguib M. Reversal of profound neuromuscular block by sugammadex administered three minutes after rocuronium : a comparison with spontaneous recovery from succinylcholine. Anesthesiology 2009; 110 : 1020-5.
7. Lowry DW, Mirakhur RK, McCarthy GJ, Carroll MT, McCourt KC. Neuromuscular effects of rocuronium during sevoflurane, isoflurane, and intravenous anesthesia. Anesth Analg 1998; 87 : 936-40.
8. Wulf H, Ledowski T, Linstedt U, Proppe D. Neuromuscular blocking effects of rocuronium during desflurane, isoflurane, and sevoflurane anaesthesia. Can J Anaesth 1998; 45 : 526-32.
9. Bock M, Klippel K, Nitsche B, Bach A, Martin E, Motsch J. Rocuronium potency and recovery characteristics during steady-state desflurane, sevoflurane, isoflurane or propofol anaesthesia. Br J Anaesth 2000; 84 : 43-7.
10. Sorgenfrei IF, Norrild K, Larsen PB. Stensballe J, Østergaard D, Prins ME, et al. Reversal of rocuronium-induced neuromuscular block by the selective relaxant binding agent sugammadex. Anesthesiology 2006; 104 : 667-74.
11. Suy K, Morias K, Cammu G, Hans P, van Duijnhoven WGF, Heeringa M, et al. Effective reversal of moderate rocuronium-or vecuronium-induced neuromuscular block with sugammadex, a selective relaxant binding agent Anesthesiology 2007; 106 : 283-8.
12. Rex C, Wagner S, Spies C, Scholz J, Rietbergen H, Heeringa M, et al. Reversal of neuromuscular blockade by sugammadex after continuous infusion of rocuronium in patients randomized to sevoflurane or propofol maintenance anesthesia. Anesthesiology 2009; 111 : 30-5.
13. Peelers P, Passer P, Smeets J, Zwiers A, de Zwart M, van de Wetering-Krebbers S, et al. Sugammadex is cleared rapidly and primarily unchanged via renal excretion. Biopharm Drug Dispos 2011; 32: 159-67.